Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian H Kushner

Showing results (21-30 of 103) with videos related to

Pageof 11
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2003
Early molecular response of marrow disease to biologic therapy is highly prognostic in neuroblastomaIrene Y Cheung, M Serena Lo Piccolo, Brian H Kushner, et al.
Journal of Pediatric Hematology/Oncology|November 16, 2004
Favorable-biology neuroblastoma presenting with leptomeningeal metastases?: a case presentationKim Kramer, Brian H Kushner, Jeffrey C Allen, et al.
Pediatric Blood & Cancer|June 24, 2008
Recurrent metastatic neuroblastoma followed by myelodysplastic syndrome: possible leukemogenic role of temozolomideBrian H Kushner, Michael P Laquaglia, Kim Kramer, et al.
Pediatric Blood & Cancer|August 28, 2009
A focal lesion in the falx cerebri: Harbinger of classic stage 4 neuroblastoma in an infant cured despite residual disease after minimal therapyBrian H Kushner, Kim Kramer, Shakeel Modak, et al.
Pediatric Blood & Cancer|August 27, 2005
Liver involvement in neuroblastoma: the Memorial Sloan-Kettering Experience supports treatment reduction in young patientsBrian H Kushner, Kim Kramer, Michael P LaQuaglia, et al.
Cancer|June 22, 2010
Differential impact of high-dose cyclophosphamide, topotecan, and vincristine in clinical subsets of patients with chemoresistant neuroblastomaBrian H Kushner, Kim Kramer, Shakeel Modak, et al.
Pediatric Blood & Cancer|January 20, 2006
High-dose cyclophosphamide inhibition of humoral immune response to murine monoclonal antibody 3F8 in neuroblastoma patients: broad implications for immunotherapyBrian H Kushner, Irene Y Cheung, Kim Kramer, et al.
Medical and Pediatric Oncology|November 5, 2003
Neuroblastoma in adolescents and adults: the Memorial Sloan-Kettering experienceBrian H Kushner, Kim Kramer, Michael P LaQuaglia, et al.
JCO Precision Oncology|August 10, 2023
Anaplastic Lymphoma Kinase Inhibitors for Therapy of Neuroblastoma in AdultsJessica Stiefel, Brian H Kushner, Stephen S Roberts, et al.
Pediatric Blood & Cancer|March 19, 2011
Plerixafor plus granulocyte-colony stimulating factor for autologous hematopoietic stem cell mobilization in patients with metastatic neuroblastomaShakeel Modak, Irene Y Cheung, Brian H Kushner, et al.
Pageof 11

Showing results (21-30 of 103) with videos related to

Sort By:
Pageof 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2003
Early molecular response of marrow disease to biologic therapy is highly prognostic in neuroblastomaIrene Y Cheung, M Serena Lo Piccolo, Brian H Kushner, et al.
Journal of Pediatric Hematology/Oncology|November 16, 2004
Favorable-biology neuroblastoma presenting with leptomeningeal metastases?: a case presentationKim Kramer, Brian H Kushner, Jeffrey C Allen, et al.
Pediatric Blood & Cancer|June 24, 2008
Recurrent metastatic neuroblastoma followed by myelodysplastic syndrome: possible leukemogenic role of temozolomideBrian H Kushner, Michael P Laquaglia, Kim Kramer, et al.
Pediatric Blood & Cancer|August 28, 2009
A focal lesion in the falx cerebri: Harbinger of classic stage 4 neuroblastoma in an infant cured despite residual disease after minimal therapyBrian H Kushner, Kim Kramer, Shakeel Modak, et al.
Pediatric Blood & Cancer|August 27, 2005
Liver involvement in neuroblastoma: the Memorial Sloan-Kettering Experience supports treatment reduction in young patientsBrian H Kushner, Kim Kramer, Michael P LaQuaglia, et al.
Cancer|June 22, 2010
Differential impact of high-dose cyclophosphamide, topotecan, and vincristine in clinical subsets of patients with chemoresistant neuroblastomaBrian H Kushner, Kim Kramer, Shakeel Modak, et al.
Pediatric Blood & Cancer|January 20, 2006
High-dose cyclophosphamide inhibition of humoral immune response to murine monoclonal antibody 3F8 in neuroblastoma patients: broad implications for immunotherapyBrian H Kushner, Irene Y Cheung, Kim Kramer, et al.
Medical and Pediatric Oncology|November 5, 2003
Neuroblastoma in adolescents and adults: the Memorial Sloan-Kettering experienceBrian H Kushner, Kim Kramer, Michael P LaQuaglia, et al.
JCO Precision Oncology|August 10, 2023
Anaplastic Lymphoma Kinase Inhibitors for Therapy of Neuroblastoma in AdultsJessica Stiefel, Brian H Kushner, Stephen S Roberts, et al.
Pediatric Blood & Cancer|March 19, 2011
Plerixafor plus granulocyte-colony stimulating factor for autologous hematopoietic stem cell mobilization in patients with metastatic neuroblastomaShakeel Modak, Irene Y Cheung, Brian H Kushner, et al.
Pageof 11